Participants 0 126 4
Double blind, placebo controlled study of metronidazole as a disease modifying agent in the treatment of rheumatoid arthritis.
Participants 154 249 3
that metronidazole may have disease modifying activity in the treatment of rheumatoid arthritis
Participants 367 540 6
Fifty patients with active rheumatoid arthritis were randomly allocated to receive active drug (n = 24) or placebo (n = 26) and reviewed at weeks 0, 1, 4, 8, 12, 16, and 24.
